Everything below concerns GHRH analog. We keep the language plain, cite what the science says, and separate well-supported claims from open questions.
Updated 2026-07-01. Numbers and descriptions here follow the published literature rather than marketing material.
Tesamorelin is a synthetic peptide analog of growth hormone-releasing hormone, built from 44 amino acids. Its sequence follows the natural human GHRH(1-44) backbone, with a trans-3-hexenoyl group attached to the N-terminal tyrosine. This modification blocks recognition by dipeptidyl peptidase IV, the enzyme that rapidly truncates the native hormone in circulation. The result is a molecule with a substantially longer plasma residence time than unmodified GHRH, which makes it practical for clinical and laboratory study.
Receptor-level activity begins when the peptide binds the GHRH receptor, a class B G-protein-coupled receptor found on pituitary somatotroph cells. Occupancy triggers Gs-mediated activation of adenylyl cyclase and a rise in intracellular cyclic AMP, which in turn promotes synthesis and pulsatile release of growth hormone. Because the compound acts upstream of the growth hormone axis rather than supplying hormone directly, its effect depends on intact pituitary function. Binding studies in cell culture and animal models have established this pathway; the detailed kinetics of receptor recycling in humans remain less well characterized.
Physicochemical behavior is dominated by the peptide backbone. The molecule is hydrophilic and carries a net positive charge near neutral pH, owing to several arginine and lysine residues. In solution it adopts a largely unstructured conformation, and aggregation is a known concern for peptide products of this size. Oxidation of methionine and deamidation of asparagine or glutamine residues are the principal chemical degradation routes. These liabilities shape how the material is formulated, handled, and analyzed, and they explain why lyophilized presentations are common in research settings.
特沙莫瑞林的检测通常依赖反相高效液相色谱和质谱联用。反相色谱可分离肽主峰与缺失序列、氧化产物等杂质，质谱则提供精确质量以确认身份。对于复杂基质中的定量，常采用液相色谱-串联质谱，并配合固相萃取或蛋白沉淀。生物样品中的肽易降解，因此采集和处理条件会影响结果。
稳定性研究通常考察温度、光照、湿度和 pH 对肽链的影响。冻干粉在低温避光条件下较为稳定，复溶后则需控制保存时间并避免反复冻融。肽类可能发生氧化、脱酰胺、水解和聚集，这些变化会改变色谱纯度。强制降解实验用于识别主要降解途径并验证分析方法的专属性。
| Property | Value | Notes |
|---|---|---|
| Molecular class | Synthetic peptide | GHRH receptor agonist |
| Residue count | 44 amino acids | Matches human GHRH(1-44) length |
| N-terminal modification | trans-3-hexenoyl group | Confers resistance to dipeptidyl peptidase IV |
| Appearance | White to off-white powder | Typically supplied lyophilized in a sealed vial |
| Solubility class | Freely soluble in water | Hydrophilic peptide; polar solvent compatible |
Tesamorelin is a synthetic peptide analog of growth hormone-releasing hormone, composed of 44 amino acids. It was designed to retain the biological activity of the native hormone while resisting rapid enzymatic degradation. The compound is classified as a growth hormone secretagogue and belongs to the broader family of hypothalamic releasing factors. In research and clinical settings, it is studied for its ability to stimulate pituitary growth hormone release. Its structure includes a modification at the N-terminus that contributes to an extended half-life relative to native growth hormone-releasing hormone.
Tesamorelin binds to growth hormone-releasing hormone receptors on the surface of pituitary somatotroph cells. This binding activates adenylate cyclase, raising intracellular cyclic AMP levels and triggering the release of growth hormone into circulation. The elevated growth hormone then stimulates hepatic production of insulin-like growth factor 1. Because the effect is mediated through the endogenous axis, secretion remains subject to feedback regulation. This distinguishes it from direct growth hormone administration, which bypasses pituitary control entirely.
冻干粉末一般在 -20°C 或更低温度、干燥避光条件下保存，可维持较长时间的稳定。复溶后稳定性明显下降，溶液中的肽链易发生水解、氧化与聚集，通常需冷藏并在短期内用完。反复冻融会加速聚集与降解，建议分装后单次使用。缓冲体系的 pH 与离子强度同样影响聚集速率，需要按具体实验条件验证。
研究用与临床用材料的标准并不相同。质量控制通常覆盖纯度、残留溶剂、反离子含量、微生物限度与内毒素水平，各项均有对应检测方法。随货文件应包含批号、检测项目、方法与结果，使数据可以追溯。核验时应关注纯度是否按主峰面积计算、杂质是否已定性、方法是否经过验证，这些信息决定结果能否被外部重复。
Tesamorelin is a synthetic analog of growth hormone-releasing hormone, a peptide hormone produced by the hypothalamus. The molecule retains the 44-amino-acid sequence of human GHRH and carries a trans-3-hexenoyl modification at its N-terminus. This modification increases resistance to enzymatic degradation and extends the peptide's functional stability relative to native GHRH. The compound is supplied as a lyophilized powder for reconstitution and subcutaneous administration in clinical settings. Its development code was TH9507, and it belongs to the GHRH analog class. It is not a growth hormone product; instead, it acts upstream to stimulate endogenous growth hormone release.
Clinical interest in tesamorelin arose from the need to address visceral adiposity in people living with HIV. Antiretroviral therapy improved survival but was associated in some patients with central fat accumulation, altered lipid profiles, and metabolic complications. This condition, often called HIV-associated lipodystrophy, involves excess visceral adipose tissue that is difficult to manage through diet and exercise alone. Investigators evaluated tesamorelin because GHRH analogs can stimulate growth hormone secretion and influence fat distribution without direct liposuction or invasive procedures.
A Phase 3 program led to regulatory approval in the United States in 2010 for reduction of excess visceral abdominal fat in adults with HIV and lipodystrophy. Subsequent studies examined effects on liver fat, muscle area, and metabolic markers, with mixed findings for some endpoints. Long-term cardiovascular outcomes and effects on mortality remain uncertain because most trials were relatively short and focused on imaging-based fat measurements. Use in populations without HIV has been studied experimentally but is not part of the approved indication.
In addition to polycondensation, automated synthesis has been applied to the various methods of radical polymerization, such as ring-opening and polyolefins. This includes free-radical polymerization, such as the development of an automated process to synthesize and evaluate molecularly imprinted polymers (MIPs). Through thermal initiation, around sixty polymers could be prepared in parallel and evaluated through their binding constants to the imprinted analytes. Furthermore, adding another approach to the repertoire, Long et al. demonstrated the abilities of robotic systems and their use with varying the monomer for the synthesis of poly(styrene-co-methyl methacrylate) and poly(styrene-co-butyl methacrylate). After automatically precipitating, the products were characterized with standard analytics and added to the polymer library. Another example includes the method described by Symyx Technologies Inc. with the application of an ink-jet printer, delivering different ratios of styrene and acrylonitrile, which was used as the terminator. While these are examples of suspension polymerization, the first instance of automated synthesis for parallel emulsion was reported by Voorn et al. with five parallel reactors containing well-defined systems of styrene and vinyl acetate. After optimizing the vortex speed, the results between the methods of automated synthesis and classical stirring for emulsion polymerization were compared, which found that the products were comparable.
== Development == Shortly after internal fertilization, the fertilized ovum enters the partially formed egg case located in the oviduct. After the ovum enters, the rest of the egg case forms around it. Shortly after the egg case finishes developing, it is deposited outside the body; common locations include kelp forests and rocky seafloors. Egg cases are typically produced in pairs, each with one fertilized embryo inside, with the exception of a few species that produce egg cases with more than one viable embryo. Gestation can take anywhere from a few months to over a year. After a period of development, typically a week or two, small slits open on each side of the egg case to aid water flow. The embryo fans its tail constantly to promote exchange with surrounding water.
=== Other injections === There is insufficient evidence on the routine use of injection therapies (autologous blood, platelet-rich plasma, deproteinised haemodialysate, aprotinin, polysulphated glycosaminoglycan, skin derived fibroblasts etc.) for treating Achilles tendinopathy. As of 2014 there was insufficient evidence to support the use of platelet-rich therapies for treating musculoskeletal soft tissue injuries such as ligament, muscle and tendon tears and tendinopathies.
Sources: en.wikipedia.org
In 1933, Norway, which occupied part of Eastern Greenland, accepted a ruling of the Permanent Court of International Justice affirming Danish sovereignty over all of Greenland and renounced its claim. The 1953 Constitution of Denmark ended Greenland's status as a colony, integrating it fully into the Danish state as a regular county, as part of decolonization efforts and with the consent of the Greenland Provincial Council. In the 1979 Greenlandic home rule referendum, Denmark granted home rule to Greenland, leading to the establishment of a local government authority with responsibility for local matters, but Greenland remains part of the Kingdom of Denmark, with the central government in Copenhagen solely responsible for defence and foreign policy. As part of the Nordic region and the Kingdom of Denmark, Greenland is an associate member of the Nordic Council. Greenland is one of the Overseas Countries and Territories of the EU. Greenlanders are Danish citizens and therefore also EU citizens. In 2009, Greenland was recognised by the Kingdom of Denmark and under international law as a people entitled to external self-determination. Most political parties in Greenland favour independence from Denmark as a long-term goal, with a draft constitution for an independent Greenlandic state presented by lawmakers in 2023, but the majority does not favour severing ties with Denmark in the short term.
^ - Indicates 2019 By- election She is the first female leader from Kerala to become the secretary of the All India Congress Committee. She is an LLB Degree holder who graduated from Kerala Law Academy in Thiruvananthapuram. She contested from Alappuzha in the 2019 Indian general election but lost to Adv. A. M. Ariff of the Communist Party of India (Marxist) by 9213 votes. In the 2019 Kerala Legislative Assembly by-elections, she won from Aroor Assembly constituency by defeating her nearest rival candidate, Manu C. Pulickal of the CPI(M) by a margin of 2,079 votes. Shanimol Osman was the only female MLA from the UDF in the 14th Kerala Legislative Assembly.
The Kuril Islands form part of the ring of tectonic instability encircling the Pacific Ocean referred to as the Ring of Fire. The islands themselves are summits of stratovolcanoes that are a direct result of the subduction of the Pacific Plate under the Okhotsk Plate, which forms the Kuril Trench some 200 kilometres (124 mi) east of the islands. The chain has around 100 volcanoes, some 40 of which are active, and many hot springs and fumaroles. There is frequent seismic activity, including a magnitude 8.5 earthquake in 1963 and one of magnitude 8.3 recorded on 15 November 2006, which resulted in tsunami waves up to 1.5 metres (5 ft) reaching the California coast. Raikoke Island, near the centre of the archipelago, has an active volcano which erupted again in June 2019, with emissions reaching 13,000 m (42,651 ft). The climate on the islands is generally severe, with long, cold, stormy winters and short and notoriously foggy summers. The average annual precipitation is 40 to 50 inches (1,020 to 1,270 mm), a large portion of which falls as snow. The Köppen climate classification of most of the Kurils is subarctic (Dfc), although Kunashir is humid continental (Dfb). However, the Kuril Islands' climate resembles the subpolar oceanic climate of southwest Alaska much more than the hypercontinental climate of Manchuria and interior Siberia, as precipitation is heavy and permafrost completely absent.
Sources: en.wikipedia.org
The principal difference is a chemical cap on the N-terminal tyrosine that prevents rapid enzymatic cleavage. Native GHRH is degraded within minutes in plasma, whereas the modified peptide persists considerably longer. The amino acid backbone otherwise mirrors the natural hormone.
No. It is a receptor agonist that stimulates the pituitary to release endogenous growth hormone. It does not contain or deliver growth hormone. Its downstream effects therefore depend on a functioning pituitary and an intact signaling pathway.
Pituitary responsiveness, receptor availability, and the natural pulsatility of the growth hormone axis all contribute. Because the compound amplifies an existing release pattern rather than overriding it, timing and physiological state matter. Individual variability in response is well documented but not fully explained.
反相高效液相色谱用于分离和纯度评估，质谱用于分子量确认。肽图谱或串联质谱可进一步验证序列。具体方法需根据样品基质和监管要求选择。